0RAM.L
VISTIN PHARMA ASA VISTIN PHARMA
£22.90
+7.76%
2026-02-24
About VISTIN PHARMA ASA VISTIN PHARMA
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; metformin direct compressible; and metformin premixed with lubricant magnesium stearate for use in plain metformin immediate release tablets. The company was founded in 1969 and is based in Oslo, Norway.
Key Fundamentals
P/E Ratio
0.38
EPS (TTM)
£0.56
ROE
21.9%
Revenue Growth (YoY)
-2.5%
Profit Margin
16.6%
Debt/Equity
0.14
Price/Book
2.66
Beta
0.62
Avg Volume (10D)
1K
Recent Breakout Signals
No recent breakout signals detected for 0RAM.L.
Recent Price Range (60 Days)
60D High
£27.60
60D Low
£20.20
Avg Volume
907
Latest Close
£22.90
Get breakout alerts for 0RAM.L
Sign up for Breakout Scanner to receive daily notifications when 0RAM.L triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
VISTIN PHARMA ASA VISTIN PHARMA (0RAM.L) is listed on the London Stock Exchange (LSE). Breakout Scanner monitors 0RAM.L daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups.. Data is provided for informational purposes only and does not constitute financial advice.